Matches in Wikidata for { <http://www.wikidata.org/entity/Q90075820> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q90075820 description "artículu científicu espublizáu en marzu de 2020" @default.
- Q90075820 description "scientific article published on 06 March 2020" @default.
- Q90075820 description "wetenschappelijk artikel" @default.
- Q90075820 description "наукова стаття, опублікована 6 березня 2020" @default.
- Q90075820 name "Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells" @default.
- Q90075820 name "Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells" @default.
- Q90075820 type Item @default.
- Q90075820 label "Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells" @default.
- Q90075820 label "Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells" @default.
- Q90075820 prefLabel "Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells" @default.
- Q90075820 prefLabel "Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells" @default.
- Q90075820 P1433 Q90075820-A098142E-5BA1-4A81-B3EA-9C479AF73997 @default.
- Q90075820 P1476 Q90075820-18F897E9-7750-453B-9184-6A2494914F76 @default.
- Q90075820 P2093 Q90075820-3AD387EA-97E8-450E-997A-23573A66B25E @default.
- Q90075820 P2093 Q90075820-80B9F4A2-0135-426B-9174-85A3472FCDA9 @default.
- Q90075820 P2093 Q90075820-CE3F4D69-426B-4FA4-9990-C50F1082F2D6 @default.
- Q90075820 P304 Q90075820-83F54323-1EA3-47D3-BB61-FE8A752DDA8B @default.
- Q90075820 P31 Q90075820-3B40542E-9131-4A4D-B8E9-F455D38093B0 @default.
- Q90075820 P356 Q90075820-C47699B3-25C4-4650-B4EC-3CCE5346D4DD @default.
- Q90075820 P50 Q90075820-EE3158FF-D5C8-48F5-B660-4F1451EF9250 @default.
- Q90075820 P577 Q90075820-E58B9B1F-8D90-4805-967E-6C3A7BB7F1E4 @default.
- Q90075820 P698 Q90075820-D236C878-1BBD-425B-BE88-1EEA367A163D @default.
- Q90075820 P921 Q90075820-9B5A25EF-53BC-4D6E-BE43-9D078D34F751 @default.
- Q90075820 P921 Q90075820-CCF7725C-A720-4468-9F12-A3E3DE78F8B9 @default.
- Q90075820 P921 Q90075820-DF58CE69-E242-40E0-BD45-DF54CEBADFB8 @default.
- Q90075820 P356 08982104.2020.1720718 @default.
- Q90075820 P698 32138557 @default.
- Q90075820 P1433 Q6295453 @default.
- Q90075820 P1476 "Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells" @default.
- Q90075820 P2093 "Mina Mirian" @default.
- Q90075820 P2093 "S Ebrahim Sajjadi" @default.
- Q90075820 P2093 "Setareh Jandaghian" @default.
- Q90075820 P304 "1-15" @default.
- Q90075820 P31 Q13442814 @default.
- Q90075820 P356 "10.1080/08982104.2020.1720718" @default.
- Q90075820 P50 Q88374337 @default.
- Q90075820 P577 "2020-03-06T00:00:00Z" @default.
- Q90075820 P698 "32138557" @default.
- Q90075820 P921 Q1138590 @default.
- Q90075820 P921 Q177094 @default.
- Q90075820 P921 Q412323 @default.